A detailed history of Massmutual Trust CO Fsb transactions in Abb Vie Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 193,945 shares of ABBV stock, worth $37.8 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
193,945
Previous 192,379 0.81%
Holding current value
$37.8 Million
Previous $35 Million 5.04%
% of portfolio
1.01%
Previous 1.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$154.79 - $180.76 $242,401 - $283,070
1,566 Added 0.81%
193,945 $33.3 Million
Q1 2024

Apr 09, 2024

SELL
$159.82 - $182.1 $3.14 Million - $3.57 Million
-19,622 Reduced 9.26%
192,379 $35 Million
Q4 2023

Jan 03, 2024

BUY
$137.6 - $154.97 $18,438 - $20,765
134 Added 0.06%
212,001 $32.9 Million
Q3 2023

Oct 03, 2023

SELL
$133.59 - $154.65 $32,996 - $38,198
-247 Reduced 0.12%
211,867 $31.6 Million
Q2 2023

Aug 01, 2023

BUY
$132.51 - $164.9 $1.31 Million - $1.62 Million
9,852 Added 4.87%
212,114 $28.6 Million
Q1 2023

Apr 11, 2023

BUY
$144.61 - $166.54 $353,860 - $407,523
2,447 Added 1.22%
202,262 $32.2 Million
Q4 2022

Jan 06, 2023

BUY
$138.31 - $165.87 $169,153 - $202,859
1,223 Added 0.62%
199,815 $32.3 Million
Q3 2022

Oct 07, 2022

BUY
$134.21 - $153.93 $28,318 - $32,479
211 Added 0.11%
198,592 $26.7 Million
Q2 2022

Jul 07, 2022

SELL
$137.62 - $174.96 $2.77 Million - $3.52 Million
-20,115 Reduced 9.21%
198,381 $30.4 Million
Q1 2022

Apr 08, 2022

BUY
$131.98 - $163.75 $85,918 - $106,601
651 Added 0.3%
218,496 $35.4 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $371,385 - $469,910
3,457 Added 1.61%
217,845 $29.5 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $3.76 Million - $4.27 Million
35,334 Added 19.73%
214,388 $23.1 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $696,279 - $775,695
6,618 Added 3.84%
179,054 $20.2 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $924,485 - $1.02 Million
9,037 Added 5.53%
172,436 $18.7 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $220,059 - $297,103
-2,734 Reduced 1.65%
163,399 $17.5 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $1 Million - $1.18 Million
11,694 Added 7.57%
166,133 $14.6 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $738,028 - $987,592
10,059 Added 6.97%
154,439 $15.2 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $42,376 - $64,248
657 Added 0.46%
144,380 $11 Million
Q4 2019

May 15, 2020

BUY
$72.13 - $90.25 $139,787 - $174,904
1,938 Added 1.37%
143,723 $12.7 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $353,569 - $425,092
5,614 Added 4.12%
141,785 $10.7 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $222,394 - $284,272
3,385 Added 2.55%
136,171 $9.9 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $697,499 - $820,923
9,042 Added 7.31%
132,786 $10.7 Billion
Q4 2018

Feb 26, 2019

SELL
$77.85 - $96.01 $203,655 - $251,162
-2,616 Reduced 2.07%
123,744 $11.4 Billion
Q3 2018

Nov 09, 2018

BUY
$88.91 - $98.84 $1.65 Million - $1.84 Million
18,611 Added 17.27%
126,360 $12 Billion
Q2 2018

Aug 20, 2018

BUY
$89.78 - $106.23 $90,857 - $107,504
1,012 Added 0.95%
107,749 $9.98 Billion
Q1 2018

May 21, 2018

SELL
$92.01 - $123.21 $147,216 - $197,136
-1,600 Reduced 1.48%
106,737 $10.1 Billion
Q4 2017

Mar 01, 2018

BUY
$89.56 - $98.21 $5.91 Million - $6.48 Million
65,960 Added 155.65%
108,337 $10.5 Billion
Q4 2017

Feb 21, 2018

SELL
$89.56 - $98.21 $5.77 Million - $6.32 Million
-64,389 Reduced 60.31%
42,377 $457 Million
Q3 2017

Feb 13, 2018

BUY
$69.85 - $89.22 $357,352 - $456,449
5,116 Added 5.03%
106,766 $9.49 Billion
Q2 2017

Aug 14, 2017

BUY
N/A
101,650
101,650 $7.37 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.